ArticleBMC oral health2024

Soluble urokinase plasminogen activator receptor (suPAR) is a potential biomarker of stage III-IV, grade C periodontitis through the impact of post-radiotherapy on head and neck cancer patients.

Ahmed A Al-Kubaisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.